Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» cell therapy
cell therapy
Novo Nordisk Foundation to establish €127 million cell therapy plant
Novo Nordisk Foundation to establish €127 million cell therapy plant
Biopharma Reporter
Novo Nordisk
cell therapy
Denmark
Flag link:
Cell therapy developer closes funding round to support diabetes program
Cell therapy developer closes funding round to support diabetes program
BioPharma Dive
cell therapy
Seraxis
funding
Eli Lilly
Flag link:
Oxford Biomedica stock soars on rosy forecast, talks to buy ABL Europe
Oxford Biomedica stock soars on rosy forecast, talks to buy ABL Europe
Reuters
Oxford BioMedica
M&A
viral vectors
ABL Europe
cell therapy
Flag link:
FDA capacity forces delay to Iovance's cell therapy
FDA capacity forces delay to Iovance's cell therapy
Pharmaphorum
Iovance Biotherapeutics
lifileucel
cell therapy
FDA
melanoma
Flag link:
BioCardia’s Cell Therapy Unlikely to Meet Primary Endpoint in Phase III Heart Failure
BioCardia’s Cell Therapy Unlikely to Meet Primary Endpoint in Phase III Heart Failure
BioSpace
BioCardia
clinical trials
cell therapy
heart failure
CardiAMP
Flag link:
Mesoblast's CEO takes 30% pay cut to fund 3rd shot at cell therapy approval
Mesoblast's CEO takes 30% pay cut to fund 3rd shot at cell therapy approval
Fierce Biotech
Mesoblast
cell therapy
FDA
Pharma CEOs
executive compensation
Flag link:
Notch Therapeutics closes Vancouver lab, will focus on Toronto and Seattle offices
Notch Therapeutics closes Vancouver lab, will focus on Toronto and Seattle offices
Geekwire
Notch Therapeutics
Vancouver
Canada
cell therapy
Flag link:
Bayer Pushes Ahead With Parkinson’s Cell Therapy on Heels of Positive Phase 1 Data
Bayer Pushes Ahead With Parkinson’s Cell Therapy on Heels of Positive Phase 1 Data
MedCity News
Bayer
cell therapy
Parkinson's Disease
clinical trials
Flag link:
Bayer preps for phase 2 after Parkinson's cell therapy clears safety bar in early-stage study
Bayer preps for phase 2 after Parkinson's cell therapy clears safety bar in early-stage study
Fierce Biotech
Bayer
Parkinson's Disease
cell therapy
bemdaneprocel
BlueRock Therapeutics
Flag link:
Aspen taps tech firms for digital Parkinson's trial
Aspen taps tech firms for digital Parkinson's trial
Pharmaphorum
Apen Neuroscience
Parkinson's Disease
cell therapy
Emerald Innovations
Rune Labs
Flag link:
BMS backs $255m round for contract cell maker Cellares
BMS backs $255m round for contract cell maker Cellares
Pharmaphorum
Cellares
funding
cell therapy
Bristol Myers Squibb
Flag link:
FDA lifts clinical hold on Gilead's CAR-T as Arcellx sheds light on reason for patient death
FDA lifts clinical hold on Gilead's CAR-T as Arcellx sheds light on reason for patient death
Fierce Biotech
Gilead Sciences
Arcellx
CAR-T
cell therapy
FDA
Flag link:
Thermo Fisher lays off 200-plus at clinical-stage cell and gene therapy factory in Florida
Thermo Fisher lays off 200-plus at clinical-stage cell and gene therapy factory in Florida
Fierce Pharma
ThermoFisher Scientific
layoffs
gene therapy
cell therapy
Flag link:
FDA Blocks Mesoblast Cell Therapy Again, Asks for More Data
FDA Blocks Mesoblast Cell Therapy Again, Asks for More Data
BioSpace
Mesoblast
remestemcel-L
FDA
graft vs host disease
cell therapy
Flag link:
Aiming to be biggest biotech in Boston, Vertex plots 500-person cell, gene therapy R&D center
Aiming to be biggest biotech in Boston, Vertex plots 500-person cell, gene therapy R&D center
Fierce Biotech
Vertex Pharmaceuticals
cell therapy
gene therapy
R&D
Boston
Flag link:
FDA rejects Mesoblast's cell therapy for bone marrow transplant complications
FDA rejects Mesoblast's cell therapy for bone marrow transplant complications
Yahoo/Reuters
Mesoblast
FDA
cell therapy
bone marrow transplants
remestemcel-L
Flag link:
3 Reasons Why Caribou Biosciences Is a Screaming Buy in July and Beyond
3 Reasons Why Caribou Biosciences Is a Screaming Buy in July and Beyond
Motley Fool
Caribou Biosciences
cell therapy
CB-010
relapsed or refractory B cell lymphoma
Flag link:
Kincell spins out of a cell therapy biotech, joining wave of manufacturing startups
Kincell spins out of a cell therapy biotech, joining wave of manufacturing startups
BioPharma Dive
Kincell
cell therapy
Flag link:
This 1 Innovation Could Make These 2 Biotechs Soar by 2030
This 1 Innovation Could Make These 2 Biotechs Soar by 2030
Motley Fool
cell therapy
Caribou Biosciences
CRISPR Therapeutics
Flag link:
Cell therapy startup Turnstone adds to biotech IPO flurry with $80M raise
Cell therapy startup Turnstone adds to biotech IPO flurry with $80M raise
BioPharma Dive
IPOs
Turnstone Biologics
cell therapy
Flag link:
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »